Cargando…
Four drug-sensitive subunits are required for maximal effect of a voltage sensor–targeted KCNQ opener
KCNQ2-5 (Kv7.2–Kv7.5) channels are strongly influenced by an emerging class of small-molecule channel activators. Retigabine is the prototypical KCNQ activator that is thought to bind within the pore. It requires the presence of a Trp side chain that is conserved among retigabine-sensitive channels...
Autores principales: | Wang, Alice W., Yau, Michael C., Wang, Caroline K., Sharmin, Nazlee, Yang, Runying Y., Pless, Stephan A., Kurata, Harley T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168237/ https://www.ncbi.nlm.nih.gov/pubmed/30166313 http://dx.doi.org/10.1085/jgp.201812014 |
Ejemplares similares
-
One drug-sensitive subunit is sufficient for a near-maximal retigabine effect in KCNQ channels
por: Yau, Michael C., et al.
Publicado: (2018) -
Pore- and voltage sensor–targeted KCNQ openers have distinct state-dependent actions
por: Wang, Caroline K., et al.
Publicado: (2018) -
Asymmetric functional contributions of acidic and aromatic side chains in sodium channel voltage-sensor domains
por: Pless, Stephan A., et al.
Publicado: (2014) -
PIP2 mediates functional coupling and pharmacology of neuronal KCNQ channels
por: Kim, Robin Y., et al.
Publicado: (2017) -
Epilepsy-associated mutations in the voltage sensor of KCNQ3 affect voltage dependence of channel opening
por: Barro-Soria, Rene
Publicado: (2019)